29 A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of OGX-011, a 2′-methoxyethyl phosphorothioate antisense to clusterin, in patients with prostate cancer prior to radical prostatectomy

✍ Scribed by K.N. Chi; E. Eisenhauer; L. Fazli; E.C. Jones; J. Powers; A. Hurtado-Coll; S.L. Goldenberg; M.E. Gleave

• Book ID: 118621214
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 136 KB
• Volume: 2
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(04)80037-5